RESUMEN
This brief historical review of pathology stresses the impact of microbial discovery on the development of pathology as a medical specialty. If, as it has been said, the microscope invented the pathologist, it was the microbe, especially the pathogenic bacterium, that gave him his name and made him clinically relevant.
Asunto(s)
Enfermedades Transmisibles/historia , Microbiología/historia , Patología/historia , Historia del Siglo XVIII , Historia del Siglo XIX , Historia del Siglo XXRESUMEN
Ofloxacin, a newer broad-spectrum fluoroquinolone, was evaluated against 6967 clinical isolates in a multicenter surveillance trial using a standardized disk diffusion method. Thirty-five geographically diverse laboratories contributed zone diameter results for two (ofloxacin and ciprofloxacin) to five (ofloxacin, ciprofloxacin, ampicillin, cefaclor, and cefixime) antimicrobial agents, depending on the site of infection. Ofloxacin was determined to have the widest spectrum of activity and potential empiric use (90.6%, range 87.1%-92.2%) for respiratory tract, urinary tract, and cutaneous infections. The spectrum was superior to ciprofloxacin (average 85.3% versus three sites), ampicillin (35.5%, respiratory tract), cefaclor (60.5%, respiratory tract), cefixime (60.9%, respiratory tract), and norfloxacin (87.3%, urinary tract). Strains resistant to ofloxacin (35 isolates, 0.5%) were confirmed by reference laboratory tests and cross resistance was observed among several current and investigational fluoroquinolone agents. The species most often found to be fluoroquinolone resistant among the Enterobacteriaceae were Klebsiella pneumoniae, Serratia marcescens, and Providencia spp. Monitoring for increasing fluoroquinolone resistance should be considered as greater use of drugs in this class develops. By these cited statistics, ofloxacin appears to have a broad and balanced spectrum of potential use, particularly against Gram-positive pathogens.
Asunto(s)
Bacterias/efectos de los fármacos , Ofloxacino/farmacología , Infecciones del Sistema Respiratorio/microbiología , Enfermedades Cutáneas Infecciosas/microbiología , Infecciones Urinarias/microbiología , Antiinfecciosos/química , Antiinfecciosos/farmacología , Farmacorresistencia Microbiana , Enterobacteriaceae/efectos de los fármacos , Haemophilus influenzae/efectos de los fármacos , Humanos , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Moraxella catarrhalis/efectos de los fármacos , Ofloxacino/química , Pseudomonas aeruginosa/efectos de los fármacos , Staphylococcus aureus/efectos de los fármacos , Streptococcus pneumoniae/efectos de los fármacos , Estados UnidosAsunto(s)
Neoplasias Encefálicas/diagnóstico , Condromatosis Sinovial/diagnóstico , Articulación Temporomandibular/patología , Biopsia con Aguja , Condromatosis Sinovial/complicaciones , Condromatosis Sinovial/patología , Diagnóstico Diferencial , Parálisis Facial/etiología , Femenino , Pérdida Auditiva Sensorineural/etiología , Humanos , Persona de Mediana Edad , Vértigo/etiologíaRESUMEN
The histological and immunohistochemical features of 3 cases of cellular neurothekeomas of skin are presented. Based on the findings in these cases and comparisons made with others reported in the literature, it is proposed that neurothekeomas may be divided into two distinct types: the myxoid and cellular variants. The relationship between these variants and a related entity, the Pacinian neurofibroma, is discussed.